| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 9 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 2 | TACROLIMUS OINTMENT 0.1% | 9 |
| 3 | EVEROLIMUS | 4 |
| 4 | EVEROLIMUS TABLETS | 4 |
| 5 | MYCOPHENOLATE MOFETIL | 4 |
| 6 | PREDNISOLONE | 4 |
| 7 | PREDNISOLONE ORAL | 4 |
| 8 | PREDNISOLONE ORAL SOLUTION | 4 |
| 9 | PREDNISONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 1 | 0.0014 |
| 1 | ACARBOSE | 1 | 0.0003 |
| 2 | EVEROLIMUS TABLETS | 4 | 0.0002 |
| 3 | MINOCYCLINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | EDOXABAN TOSYLATE | 1 | 0.0001 |
| 5 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 7 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 1 | 0.0001 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | QUININE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 9 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |